BILIRUBIN METABOLISM
About 4 mg/kg of bilirubin is produced each day, mainly (80 to 85 per cent) derived from the catabolism of the hemoglobin heme group of senescent red blood cells. The heme group is cleaved in the reticuloendothelial system to form biliverdin, which in turn is oxidized to bilirubin, a waterinsoluble, linear tetrapyrrole (Fig. 36-5). A smaller proportion of bilirubin (15 to 20 per cent) is derived from the destruction of maturing eryth-roid cells in the bone marrow (ineffective eryth-ropoiesis) and from the heme groups of predominantly hepatic hemoproteins such as cytochrome P-450 and cytochrome c.
Bilirubin liberated into the plasma is transported to the liver bound tightly but reversibly to albumin. Three phases of hepatic bilirubin metabolism are recognized: (1) uptake, (2) conjugation, and (3) excretion into the bile, the last step being overall rate-limiting (Fig. 36-6). Uptake is reversible and follows dissociation of bilirubin from albumin. Unconjugated bilirubin is insoluble in water and is virtually incapable of being excreted in bile. This apolar molecule, however, dissolves in lipid-rich environments and readily traverses the blood-brain barrier and placenta.
The major physiological process for rendering bilirubin water-soluble, and hence capable of being excreted in the aqueous bile, is its conjugation with the sugar glucuronic acid. Mono and diglucuronides of bilirubin are formed in the hepatic endoplasmic reticulum catalyzed by the enzyme UDP-glucuronyl transferase. If the biliary excretion of conjugated bilirubin is impaired, the pigment from hepatocytes regurgitates into plasma. Conjugated bilirubin is both watersoluble and less tightly bound to albumin than unconjugated pigment, so that it is readily filtered by the glomerulus and appears in the urine when plasma levels are increased. Unconjugated bilirubin is not excreted in urine. With sustained conjugated hyperbilirubinemia (e.g., obstructive jaundice), a proportion of the conjugated bilirubin becomes covalently bound to albumin and is therefore unavailable for renal or biliary excretion.
Conjugated bilirubin excreted in the bile is not reabsorbed by the intestine but is converted by bacterial action in the gut to colorless tetrapyr-roles termed urobilinogens. Up to 20 per cent of urobilinogen is reabsorbed and undergoes an enterohepatic circulation, a proportion being excreted in the urine. Thus, both impaired hepatocellular excretion and marked overproduction of bilirubin lead to increased appearance of urobilinogen in the urine.
- SPECIFIC CLINICAL DISORDERS
- Therapy
- TREATMENT OF MALABSORPTION
- C. MALABSORPTION
- Treatment
- CLASSIFICATION AND PATHOPHYSIOLOGY
- NORMAL ABSORPTION
- Initial Assessment
- CLASSIFICATION OF THE MALABSORPTION SYNDROMES
- CLINICAL TESTS OF DIGESTION AND ABSORPTION
- NORMAL INTESTINAL PHYSIOLOGY
- BILIRUBIN METABOLISM
- DISORDERS ASSOCIATED WITH MALABSORPTION
- APPROACH TO THE PATIENT WJTH SUSPECTED MALDIGESTION AND/OR MALABSORPTION
- History and Physical Examination
- Resuscitation
- Diagnosis
- DEFINITION
- DEFINITION
- CLINICAL MANIFESTATIONS OF MALABSORPTION